BMED vs. GERM
BMED (Future Health ETF) and GERM (Amplify Treatments, Testing and Advancements ETF) are both Health & Biotech Equities funds. BMED is actively managed, while GERM is passively managed. Over the past year, BMED returned 17.59% vs 0.00% for GERM. BMED charges 0.85%/yr vs 0.68%/yr for GERM.
Performance
BMED vs. GERM - Performance Comparison
Loading charts...
Returns By Period
BMED
- 1D
- 1.98%
- 1M
- 2.19%
- YTD
- -5.19%
- 6M
- -5.93%
- 1Y
- 17.59%
- 3Y*
- 5.91%
- 5Y*
- -0.08%
- 10Y*
- —
GERM
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.00%
- 1Y
- 0.00%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
BMED vs. GERM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
BMED Future Health ETF | -5.19% | 21.79% | -2.83% |
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% |
BMED vs. GERM - Sectors Allocation Comparison
Sectors
BMED
GERM
Healthcare
Consumer Defensive
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Energy
-
-
Financial Services
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
BMED
GERM
Consumer Defensive
BMED
GERM
-
Basic Materials
BMED
-
GERM
-
Communication Services
BMED
-
GERM
-
Consumer Cyclical
BMED
-
GERM
-
Energy
BMED
-
GERM
-
Financial Services
BMED
-
GERM
Industrials
BMED
-
GERM
-
Real Estate
BMED
-
GERM
-
Technology
BMED
-
GERM
-
Utilities
BMED
-
GERM
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BMED vs. GERM — Risk / Return Rank
BMED
GERM
BMED vs. GERM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Future Health ETF (BMED) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BMED | GERM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.20 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.19 | — | — |
| Martin ratioReturn relative to average drawdown | 3.00 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BMED | GERM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.16 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.00 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.12 | — | — |
Drawdowns
BMED vs. GERM - Drawdown Comparison
The maximum BMED drawdown since its inception was -36.44%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for BMED and GERM.
Loading charts...
Drawdown Indicators
| BMED | GERM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -36.44% | 0.00% | -36.44% |
Max Drawdown (1Y)Largest decline over 1 year | -14.85% | 0.00% | -14.85% |
Max Drawdown (3Y)Largest decline over 3 years | -20.12% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -33.90% | — | — |
Current DrawdownCurrent decline from peak | -11.17% | 0.00% | -11.17% |
Average DrawdownAverage peak-to-trough decline | -19.08% | 0.00% | -19.08% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.88% | 0.00% | +5.88% |
Volatility
BMED vs. GERM - Volatility Comparison
Future Health ETF (BMED) has a higher volatility of 4.74% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that BMED's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BMED | GERM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.74% | 0.00% | +4.74% |
Volatility (6M)Calculated over the trailing 6-month period | 11.23% | 0.00% | +11.23% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.23% | 0.00% | +15.23% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.43% | 0.00% | +17.43% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.77% | 0.00% | +17.77% |
BMED vs. GERM - Expense Ratio Comparison
BMED has a 0.85% expense ratio, which is higher than GERM's 0.68% expense ratio.
Dividends
BMED vs. GERM - Dividend Comparison
Neither BMED nor GERM has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
BMED Future Health ETF | 0.00% | 0.00% | 0.00% | 0.03% |
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
BMED has higher volatility (4.74%) compared to GERM (0.00%). In terms of maximum drawdown, BMED dropped -36.44% vs GERM's 0.00%.
On 1-year performance, BMED leads with 17.59% vs 0.00% for GERM. On fees, GERM is cheaper at 0.68% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, BMED has performed better with a 17.59% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
GERM is cheaper with a 0.68% expense ratio, compared with 0.85% for BMED.
BMED and GERM have nearly identical dividend yields, around 0.00%.
They also come from different issuers: BlackRock and Amplify. Their fees differ too: 0.85% for BMED and 0.68% for GERM.
Find the right allocation for BMED and GERM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer